Suzhou NeuPharma, Coronado Biosciences deal

NeuPharma granted Coronado exclusive rights to develop and commercialize irreversible EGFR inhibitors outside undisclosed Asian countries. NeuPharma will receive an upfront payment and is eligible fo...